Understanding Your Responsibilities When Importing, Compounding And Supplying Unapproved Peptide Products

Unapproved peptide products are being imported and supplied across Australia without proper safety approval, and regulators are concerned about the health risks they may pose. These products include peptides that have not been evaluated or authorized by health authorities before being made available to consumers. This notice applies to anyone importing, manufacturing, selling, or advertising these unapproved peptide products in Australia.

Reason

We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products and the potential safety risks associated with these goods.

Classification

Class II

Category

drug recall

Country

Australia

Agency

Therapeutic Goods Administration

Recall date

2026-04-13

Status

Ongoing

Distribution

Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/50a1a5b0-dcf5-4336-8357-d2cd7c5ac8dc